Asthma drug could halve chance of developing Parkinson’s

News

Author: Parkinson's Life editorsPublished: 28 September 2017

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Asthma medication

A recent study has found that a drug most commonly used for asthma may cut the chances of developing Parkinson’s.

The research, carried out by Harvard Medical School, Massachusetts, US, found that those who inhaled salbutamol – a drug found in inhalers – were half as likely to develop the condition.

In Parkinson’s disease, a protein named a-synuclein accumulates in various brain cells and can be fatal. To counter this, the research team grew human nerve cells and tested over 1000 medications, finding results to suggest salbutamol could cut the production of a-synuclein.

Neurologist Anthony Lang, who works at the University of Toronto, Canada, said the results were “fascinating” and “had come out of the blue”.

Despite some encouraging developments, Clemens Scherzer, who was a part of the research team, said clinical trials were “a few years off”.

Go Back

Share this story

Comments


Related articles


PD in Practice

Which physiotherapy treatment is right for you?

Physiotherapy guidelines reveal best treatments – including Tai Chi

READ MORE
n My Country Denmark lead

In my country

How New York inspired Copenhagen to walk for Parkinson’s

‘Exercise is medicine’: the Danish Parkinson’s Association’s motto

READ MORE
Sabine smiles for a photo.

sponsored article

PD in Practice

“Telemedicine has the potential to take a great deal of burden off patients and families”

A neurologist and a person with Parkinson’s disease talk remote care

READ MORE